Aurora A kinase activates YAP signaling in triple-negative breast cancer

被引:0
|
作者
S-S Chang
H Yamaguchi
W Xia
S-O Lim
Y Khotskaya
Y Wu
W-C Chang
Q Liu
M-C Hung
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Molecular and Cellular Oncology
[2] Cancer Biology Program,Department of Breast Medical Oncology
[3] The University of Texas Graduate School of Biomedical Sciences at Houston,Department of Biotechnology
[4] Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy,undefined
[5] The University of Texas MD Anderson Cancer Center,undefined
[6] The University of Texas MD Anderson Cancer Center,undefined
[7] Center for Molecular Medicine and Graduate Institute of Cancer Biology,undefined
[8] China Medical University,undefined
[9] Sun Yat-Sen University Cancer Center,undefined
[10] State Key Laboratory of Oncology in South China,undefined
[11] Collaborative Innovation Center of Cancer Medicine,undefined
[12] Institute of Cancer Stem Cell,undefined
[13] First Affiliated Hospital Collaborative Innovation Center of Oncology,undefined
[14] Dalian Medical University,undefined
[15] Asia University,undefined
来源
Oncogene | 2017年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Yes-associated protein (YAP) is an effector that transduces the output of the Hippo pathway to transcriptional modulation. Considering the role of YAP in cancers, this protein has emerged as a key node in malignancy development. In this study, we determined that Aurora A kinase acts as a positive regulator for YAP-mediated transcriptional machinery. Specifically, YAP associates with Aurora A predominantly in the nucleus. Activation of Aurora A can impinge on YAP activity through direct phosphorylation. Moreover, aberrant expression of YAP and Aurora A signaling is highly correlated with triple-negative breast cancer (TNBC). We herein provide evidence to establish the functional relevance of this newly discovered regulatory axis in TNBC.
引用
收藏
页码:1265 / 1275
页数:10
相关论文
共 50 条
  • [41] Targeting Akt3 Signaling in Triple-Negative Breast Cancer
    Chin, Y. Rebecca
    Yoshida, Taku
    Marusyk, Andriy
    Beck, Andrew H.
    Polyak, Kornelia
    Toker, Alex
    CANCER RESEARCH, 2014, 74 (03) : 964 - 973
  • [42] Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
    Giuli, M. V.
    Giuliani, E.
    Screpanti, I.
    Bellavia, D.
    Checquolo, S.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [43] Theranostics for Triple-Negative Breast Cancer
    Choi, Hyeryeon
    Kim, Kwangsoon
    DIAGNOSTICS, 2023, 13 (02)
  • [44] Advanced Triple-Negative Breast Cancer
    Patel, Grisma
    Prince, Alison
    Harries, Mark
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [45] What is triple-negative breast cancer?
    Irvin, William J., Jr.
    Carey, Lisa A.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2799 - 2805
  • [46] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01): : 59 - 66
  • [47] Pembrolizumab in Triple-Negative Breast Cancer
    Altundag, Kadri
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (15): : 1435 - 1436
  • [48] A Review of Triple-Negative Breast Cancer
    Ismail-Khan, Roohi
    Bui, Marilyn M.
    CANCER CONTROL, 2010, 17 (03) : 173 - 176
  • [49] Triple-negative breast cancer: an update
    Boolbol, Susan K.
    Cate, Sarah P.
    BREAST CANCER MANAGEMENT, 2014, 3 (02) : 127 - 129
  • [50] Morphotypes of the triple-negative breast cancer
    Koleckova, M.
    Kolar, Z.
    Ehrmann, J.
    Korinkova, G.
    Trojanec, R.
    VIRCHOWS ARCHIV, 2017, 471 : S296 - S296